MinervaX is listed on the portfolio pages of EQT Partners (portfolio page) and Trill Impact (portfolio page). EQT Partners and Trill Impact list it as current.
MinervaX is a Life Sciences company. Its owner on record, EQT Partners, is a private equity firm founded in 1994, headquartered in Stockholm, Sweden, with €266 billion ($285 billion) under management. EQT Partners lists 358 companies in the index, 104 of them in Life Sciences. Also backed by Trill Impact.
EQT AB is a leading Swedish global investment organization that manages a variety of investment funds across several asset classes.
Read the EQT Partners profileTrill Impact is a private markets firm that invests in companies and debt aiming to deliver financial returns through investments that matter for current and future generations.
Read the Trill Impact profileMinervaX is listed on the portfolio pages of EQT Partners (portfolio page) and Trill Impact (portfolio page). EQT Partners and Trill Impact list it as current.
MinervaX is in Life Sciences. Classified from the owner's portfolio label.
EQT Partners is headquartered in Stockholm, Sweden.
EQT Partners lists 103 other Life Sciences companies in the index, including 3Shape, Aerska, Agomab Therapeutics, AIG Hospitals and Am-Pharma.
6 of 357 shown
See the full EQT Partners portfolio.
6 of 19 shown
See the full Trill Impact portfolio.
Browse PE-backed companies.
